During Tuesday’s Current trade, Shares of Avery Dennison Corp (NYSE:AVY), lost -0.91% to $64.09.
Vogue International, the makers of OGX hair care products collaborated with WS Packaging Group, Inc. and Avery Dennison (AVY) to reduce the environmental impacts of pressure-sensitive labels on packaging.
According to Vogue, using the Avery Dennison GreenprintTM methodology, a life cycle-based environmental performance assessment tool, an evaluation was conducted to show that using thinner label materials will reduce environmental impacts. The Greenprint tool, launched in 2010, is the first life-cycle based tool in the label industry and can assist brands make environmental decisions about labels.
Avery Dennison Corporation produces and sells pressure-sensitive materials worldwide. It operates through Pressure-Sensitive Materials, Retail Branding and Information Solutions, and Vancive Medical Technologies segments. The Pressure-sensitive Materials segment offers pressure-sensitive label and packaging materials, graphics, reflective products, tapes, and performance polymers.
Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), inclined 10.92% to $23.42, during its current trading session.
Halozyme Therapeutics, Inc. (HALO) declared the Pancreas Center at the University of California, San Francisco (UCSF) has initiated a clinical research study of Halozyme’s investigational new drug, PEGPH20 in pancreatic cancer patients who are candidates for potentially curative surgery. The trial will be conducted within the UCSF Helen Diller Family Comprehensive Cancer Center.
The Phase 2 study will investigate PEGPH20 in combination with gemcitabine and nab-paclitaxel (ABRAXANE) in patients with borderline resectable Pancreatic Ductal Adenocarcinoma (PDAC). The study will track the progress of up to 36 patients through chemotherapy and surgical treatment.
PEGPH20 (PEGylated recombinant human hyaluronidase) targets the degradation of hyaluronan (HA), a chain of natural sugars that can accumulate around cancer cells, inhibiting other therapies. By degrading HA, PEGPH20 may enhance the access of co-administered chemotherapeutic and immunotherapeutic agents.
Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter abnormal tissue structures for clinical benefit.
Primero Mining Corp (NYSE:PPP), during its Tuesday’s current trading session decreased -0.51% to $2.94.
Primero Mining Corp. (PPP) advises that as a result of a delay in exports from its San Dimas mine in Mexico, its partner Primero Empresa Minera S.A. de C.V. (“PEM”) has been delayed in selling silver. As a result about 880,000 ounces of silver were not sold during the second quarter of 2015, representing about $6.5 million in delayed revenue.
PEM’s import and export licences were suspended in May 2015 by the Mexican customs authorities due to a discrepancy over the Company’s address related to its corporate office relocation from Mexico City to Durango, Mexico. PEM has since clarified the discrepancy and has been meeting with customs officials, but has regrettably not been reinstated to the customs registry. PEM is able to source necessary supplies locally so that the San Dimas mine and mill continue to operate uninterrupted.
Primero Mining Corp., a precious metals producer, engages in the acquisition, exploration, development, and operation of mineral resource properties in Canada and Mexico. The company primarily explores for gold and silver. It owns interest in the San Dimas Mine, which is located in San Dimas district, Mexico; and the Black Fox Complex that is located in the Timmins Mining District in Ontario, Canada.
Finally, Clorox Co (NYSE:CLX), gained 0.01%, to $117.07.
The Clorox Company (CLX) will be recognized at the 2015 White House Conference on Aging as one of the companies with a “best in class” retirement plan for its employees. The conference, held once every 10 years, will feature an open dialogue on retirement and aging issues. Over 200 stakeholders will be in attendance, counting President Barack Obama, cabinet members and other CEOs, with thousands more participating through webcasts.
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates in four segments: Cleaning, Household, Lifestyle, and International. It offers laundry products, counting bleach products under the Clorox brand, and stain fighter and color booster products under the Clorox 2 brand; home-care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived home care products under the Green Works brand; and cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
